Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04520698 · ClinicalTrials.gov registry record · NA

Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease

A NA study of Alzheimer Disease, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
1,322
Enrollment target
1
Study location

NCT04520698 is a NA study of Alzheimer Disease that has completed, run by Indiana University. The registered enrollment target is 1,322 participants, below the 2,746-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04520698, a NA study of Alzheimer Disease, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
1,322 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families facing serious or life-threatening illnesses, through the prevention and relief of suffering through the treatment of pain and other problems, using physical, psychosocial and spiritual approaches. Palliative care is specialized medical care for people who are living with a serious illness. This type of care is focused on providing relief from the symptoms and from the stress of the illness. The goal is to improve quality of life for both patient and family. The UPLIFT-AD model will include providing education on primary Palliative Care for residents with dementia to nursing facility staff, training nursing facility staff in providing primary Palliative Care, and providing access to specialty Palliative Care consultations for residents. To help understand the impact of these interventions, this study will also collect information about resident health, the care they receive, and perceptions of their quality of life according to both family members and nursing facility staff.

Conditions Studied

Interventions

  • BEHAVIORAL UPLIFT-AD

Study Locations (1)

Indiana

  • American Senior Communities - Indianapolis

Trial Details

FieldValue
Enrollment Target 1,322 participants
Start Date 2021-09-08
Est. Completion 2025-09-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT04520698

The ClinicalTrials.gov registry entry for NCT04520698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,322 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,746-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (52% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which UPLIFT-AD is the first listed.

NCT04520698 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04520698 about?

NCT04520698 is a clinical study titled "Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease". The purpose of this study is to evaluate a comprehensive model for integrating both primary and specialty Palliative Care for older adults with dementia into nursing facilities. Palliative Care is a supportive care approach that aims to improve the quality of life of patients and their families faci...

What is the current status of trial NCT04520698?

This trial is currently completed. It is a NA study. The enrollment target is 1,322 participants. The study started on 2021-09-08. Estimated completion is 2025-09-30.

What conditions does trial NCT04520698 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT04520698?

The interventions under investigation include: UPLIFT-AD (BEHAVIORAL).

Who is sponsoring clinical trial NCT04520698?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04520698 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.